Organ Transplant Patients May Benefit From 3rd Dose Of Vaccines, Study Finds : Shots - Health News - NPR
A small new study offers a glimmer of hope that giving organ transplant recipients a third dose of the COVID-19 vaccine could boost their protection against the coronavirus.That's important because prior research has shown that nearly half of organ transplant recipients failed to show any antibody response even after two doses of the Pfizer or Moderna vaccine.are living with organ transplants, according to the Scientific Registry of Transplant Recipients.
In the new study, published this week in the Annals of Internal Medicine, researchers from Johns Hopkins School of Medicine tracked 30 organ transplant recipients who got a third dose of COVID-19 vaccines.The researchers say their findings support the use of clinical trials to determine whether transplant recipients should receive COVID-19 vaccine boosters as part of standard clinical care.In fact, in France health officials already recommend that severely immunocompromised patients, including organ transplant patients, dialysis patients, and others, receive a third dose of the Pfizer or Moderna vaccine.